PAVmed Inc. Common Stock (PAVM) Stock Price

PAVMStock

$2.41−83.72%52W

Market Cap$19.27M

P/E48.06x

PEG Ratio—

Div yield—

Beta0.88

PAVM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-83.60%

Price vs S&P 500 (4W)-37.97%

VGM Score35.20

P/E Ratio (Annual)48.06x

Book Value / Share (Quarterly)$5.59

P/TBV (Annual)3.63x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-42.83%

Cash Flow / Share (Quarterly)$-1.24

Price vs S&P 500 (YTD)-75.52%

Gross Margin (TTM)-220.54%

Net Profit Margin (TTM)-10794.64%

EPS (TTM)$-9.80

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-9.80

EPS (Annual)$0.60

ROI (Annual)0.89%

Gross Margin (Annual)-207.04%

Net Profit Margin (5Y Avg)-6841.93%

Cash / Share (Quarterly)$0.65

P/E Basic Excl Extra (TTM)89.09x

Revenue Growth QoQ (YoY)450.00%

P/E Normalized (Annual)48.06x

ROA (Last FY)1.03%

Revenue Growth TTM (YoY)-89.02%

EBITD / Share (TTM)$-12.72

ROE (5Y Avg)-440.28%

Operating Margin (TTM)-26898.21%

Cash Flow / Share (Annual)$-5.64

P/B Ratio0.55x

P/B Ratio (Quarterly)1.21x

Net Income / Employee (Annual)$9,800

EV / Revenue (TTM)270.54x

Net Interest Coverage (TTM)-166.22x

ROA (TTM)-29.76%

EV / EBITDA (TTM)0.69x

EPS Incl Extra (Annual)$0.60

Current Ratio (Annual)0.17x

Quick Ratio (Quarterly)1.05x

3-Month Avg Trading Volume0.03M

52-Week Price Return-83.72%

P/E Incl Extra (TTM)89.09x

Revenue / Employee (TTM)$2,700

Tangible BV / Share (Quarterly)$0.05

P/S Ratio (Annual)271.41x

Asset Turnover (Annual)0.00x

52-Week High$28.44

Operating Margin (5Y Avg)-13979.48%

EPS Excl Extra (Annual)$0.60

CapEx CAGR (5Y)-12.37%

26-Week Price Return-73.69%

Quick Ratio (Annual)0.15x

13-Week Price Return-59.32%

Total Debt / Equity (Annual)0.33x

Current Ratio (Quarterly)1.19x

Enterprise Value$30.30M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,700

Pretax Margin (Annual)-3477.46%

Cash / Share (Annual)$2.10

3-Month Return Std Dev100.57%

Gross Margin (5Y Avg)-260.22%

Net Income / Employee (TTM)$-294,900

ROE (Last FY)1.18%

Net Interest Coverage (Annual)-0.84x

EPS Basic Excl Extra (Annual)$0.60

Receivables Turnover (TTM)11.79x

Total Debt / Equity (Quarterly)0.43x

EPS Incl Extra (TTM)$-9.80

Receivables Turnover (Annual)4.30x

ROI (TTM)-25.15%

P/S Ratio (TTM)172.06x

Pretax Margin (5Y Avg)-8831.06%

Revenue / Share (Annual)$0.11

Tangible BV / Share (Annual)$0.69

Price vs S&P 500 (52W)-99.25%

P/E Ratio (TTM)89.09x

Year-to-Date Return-63.60%

5-Day Price Return-10.41%

EPS Normalized (Annual)$0.60

ROA (5Y Avg)-57.14%

Net Profit Margin (Annual)564.79%

Month-to-Date Return-34.69%

Cash Flow / Share (TTM)$-0.82

EBITD / Share (Annual)$-32.45

Operating Margin (Annual)-30794.37%

ROI (5Y Avg)-120.16%

P/E Excl Extra (TTM)89.09x

LT Debt / Equity (Quarterly)0.43x

EPS Basic Excl Extra (TTM)$-9.80

P/TBV (Quarterly)15.65x

P/B Ratio (Annual)0.19x

Inventory Turnover (TTM)34.81x

Pretax Margin (TTM)-14669.64%

Book Value / Share (Annual)$36.61

Price vs S&P 500 (13W)-62.01%

Beta0.88x

Revenue / Share (TTM)$0.02

ROE (TTM)-33.51%

52-Week Low$2.22

vGradeC

gGradeC

mGradeF

vgmGradeD

PAVM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$0.63	-$0.27	+57.14%(+$0.36)
Q1 2026	May 15, 2026	-$0.69	-$1.17	-69.57%(-$0.48)
Q4 2025	Mar 30, 2026	-$4.50	-$1.05	+76.67%(+$3.45)
Q3 2025	Nov 13, 2025	-$6.00	-$0.60	+90.00%(+$5.40)
Q2 2025	Aug 14, 2025	-$7.50	-$1.50	+80.00%(+$6.00)

PAVM Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
PAVMPAVmed Inc. Common Stock	C	C	F	172.1x	—	-220.5%	-26898.2%	$2.41
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About PAVmed Inc. Common Stock

PAVmed Inc is a commercial-stage medical technology company developing products across diagnostics, medical devices, and digital health. Its portfolio includes EsoGuard, esocheck, and the Veris Cancer Care Platform. The company is advancing its pipeline through commercialization to serve multiple healthcare markets.

PAVM Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.66

Revenue estimate$25,000

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

BCHTBirchtech Corp.Measuring & Controlling Devices
MLSSMilestone Scientific, Inc. Common StockOrthopedic & Prosthetic Devices
ITOCiTonic Holdings Ltd Class A Ordinary SharesElectromedical Equipment
DAIOData I/O CorpInstruments for Measuring
LFWDLifeward Ltd. Ordinary SharesOrthopedic & Prosthetic Devices
CLIRClearSign Technologies Corporation Common Stock (DE)Industrial Instruments
BNGOBionano Genomics, Inc. Common StockLab Analytical Instruments
IRIXIridex CorpElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$2.22

High$28.44